Marchese AM - Search Results

1

Pivoting to protein: the immunogenicity and safety of protein-based NVX-CoV2373 as a heterologous booster for inactivated and viral vector COVID-19 vaccines.

Marchese AM, Kalkeri R, Vadivale M, Suntronwong N, Toback S, Poovorawan Y. Marchese AM, et al. Expert Rev Vaccines. 2023 Jan-Dec;22(1):620-628. doi: 10.1080/14760584.2023.2232020. Expert Rev Vaccines. 2023. PMID: 37386785 Free article.

2

NVX-CoV2373 vaccine efficacy against hospitalization: A post hoc analysis of the PREVENT-19 phase 3, randomized, placebo-controlled trial.

Marchese AM, Zhou X, Kinol J, Underwood E, Woo W, McGarry A, Beyhaghi H, Áñez G, Toback S, Dunkle LM. Marchese AM, et al. Vaccine. 2023 May 22;41(22):3461-3466. doi: 10.1016/j.vaccine.2023.04.054. Epub 2023 Apr 29. Vaccine. 2023. PMID: 37127523 Free PMC article. Clinical Trial.

3

XBB.1.5 spike protein COVID-19 vaccine induces broadly neutralizing and cellular immune responses against EG.5.1 and emerging XBB variants.

Patel N, Trost JF, Guebre-Xabier M, Zhou H, Norton J, Jiang D, Cai Z, Zhu M, Marchese AM, Greene AM, Mallory RM, Kalkeri R, Dubovsky F, Smith G. Patel N, et al. Among authors: marchese am. Sci Rep. 2023 Nov 6;13(1):19176. doi: 10.1038/s41598-023-46025-y. Sci Rep. 2023. PMID: 37932354 Free PMC article.

4

The Novavax Heterologous Coronavirus Disease 2019 Booster Demonstrates Lower Reactogenicity Than Messenger RNA: A Targeted Review.

Marchese AM, Rousculp M, Macbeth J, Beyhaghi H, Seet BT, Toback S. Marchese AM, et al. J Infect Dis. 2024 Aug 16;230(2):e496-e502. doi: 10.1093/infdis/jiad519. J Infect Dis. 2024. PMID: 37992183 Free PMC article. Review.

5

Burden and Impact of Reactogenicity among Adults Receiving COVID-19 Vaccines in the United States and Canada: Results from a Prospective Observational Study.

Rousculp MD, Hollis K, Ziemiecki R, Odom D, Marchese AM, Montazeri M, Odak S, Jackson L, Miller A, Toback S. Rousculp MD, et al. Among authors: marchese am. Vaccines (Basel). 2024 Jan 13;12(1):83. doi: 10.3390/vaccines12010083. Vaccines (Basel). 2024. PMID: 38250896 Free PMC article.

6

Altered IgG4 Antibody Response to Repeated mRNA versus Protein COVID Vaccines.

Kalkeri R, Zhu M, Cloney-Clark S, Plested JS, Parekh A, Gorinson D, Cai R, Mahato S, Ramanathan P, Aurelia LC, Selva KJ, Marchese AM, Fries L, Chung AW, Dunkle LM. Kalkeri R, et al. Among authors: marchese am. medRxiv [Preprint]. 2024 Jan 18:2024.01.17.24301374. doi: 10.1101/2024.01.17.24301374. medRxiv. 2024. Update in: J Infect. 2024 Mar;88(3):106119. doi: 10.1016/j.jinf.2024.106119 PMID: 38293205 Free PMC article. Updated. Preprint.

7

Altered IgG4 antibody response to repeated mRNA versus recombinant protein SARS-CoV-2 vaccines.

Kalkeri R, Zhu M, Cloney-Clark S, Plested JS, Parekh A, Gorinson D, Cai R, Mahato S, Ramanathan P, Aurelia LC, Selva KJ, Marchese AM, Fries L, Chung AW, Dunkle LM. Kalkeri R, et al. Among authors: marchese am. J Infect. 2024 Mar;88(3):106119. doi: 10.1016/j.jinf.2024.106119. Epub 2024 Feb 13. J Infect. 2024. PMID: 38360356 Free article. No abstract available.

8

Safety and immunogenicity of the NVX-CoV2373 vaccine as a booster in adults previously vaccinated with the BBIBP-CorV vaccine.

Toback S, Marchese AM, Warren B, Ayman S, Zarkovic S, ElTantawy I, Mallory RM, Rousculp M, Almarzooqi F, Piechowski-Jozwiak B, Bonilla MF, Bakkour AE, Hussein SE, Al Kaabi N. Toback S, et al. Among authors: marchese am. Vaccine. 2024 Mar 7;42(7):1777-1784. doi: 10.1016/j.vaccine.2024.02.037. Epub 2024 Feb 15. Vaccine. 2024. PMID: 38365482 Free article. Clinical Trial.

9

Reactogenicity Differences between Adjuvanted, Protein-Based and Messenger Ribonucleic Acid (mRNA)-Based COVID-19 Vaccines.

Rousculp MD, Hollis K, Ziemiecki R, Odom D, Marchese AM, Montazeri M, Odak S, Jackson L, Beyhaghi H, Toback S. Rousculp MD, et al. Among authors: marchese am. Vaccines (Basel). 2024 Jul 19;12(7):802. doi: 10.3390/vaccines12070802. Vaccines (Basel). 2024. PMID: 39066440 Free PMC article.

10

Mechanisms and implications of IgG4 responses to SARS-CoV-2 and other repeatedly administered vaccines.

Marchese AM, Fries L, Beyhaghi H, Vadivale M, Zhu M, Cloney-Clark S, Plested JS, Chung AW, Dunkle LM, Kalkeri R. Marchese AM, et al. J Infect. 2024 Oct 16;89(6):106317. doi: 10.1016/j.jinf.2024.106317. Online ahead of print. J Infect. 2024. PMID: 39419185 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters